| AAPCC | adjusted annual per capita cost; adjusted average per capita cost; American Association of Poison Co... |
|---|---|
| FCS | faciocutaneoskeletal syndrome; fecal containment system; feedback control system; fetal calf serum; ... |
| MCL | maximum containment laboratory; medial collateral ligament; midclavicular line; midcostal line; mini... |
| Dr | Med Doctor of Medicine |
| IDDM-MED | insulin-dependent diabetes mellitus-multiple epiphyseal dysplasia [syndrome] |
| AHCCCS | Arizona Health Care Cost Containment System |
|---|---|
| MED | Medical Entities Dictionary |
| MED | Minimal effective dose |
| MED | Minimal Erythema Dose |
| Med | Motor end-plate disease |
| grateful med | A microcomputer-based software package providing a user-friendly interface to the medlars system of the national library of medicine. (12 Dec 1998) |
|---|---|
| biological containment | <molecular biology> Refers to any number of methods to contain genetically engineered organisms by creating biochemical barriers to prevent them from growing outside the laboratory. In the case of bacteria and yeasts, genes in the organisms may be altered so that they need to have a supply of a nutrient that is normally found only in the laboratory. (21 Mar 1998) |
| physical containment | <cell culture> Creation of physical barriers to keep genetically engineered organisms inside the laboratory. (31 Dec 1997) |
| plasma containment | <physics> In physics experiments or nuclear fusion experiments, operation is intended to prevent, in an effective and sufficiently prolonged manner, the particles of a plasma from striking the walls of the container in which this plasma is produced. Plasma confinement is a fundamental requirement for obtaining net energy from a fusion plasma. The reason is that scattering (hence diffusion) is at least an order of magnitude more probable than fusion reactions. Hence, without confinement, the plasma fuel would disperse before enough fusion reactions could take place. (31 Dec 1997) |
| containment | The concept of regional or global eradication of communicable disease, proposed by Fred Lowe Soper (1893-1977) in 1949 for the eradication of smallpox. (05 Mar 2000) |
| containment of biohazards | Provision of physical and biological barriers to the dissemination of potentially hazardous biologically active agents (bacteria, viruses, recombinant DNA, etc.). Physical containment involves the use of special equipment, facilities, and procedures to prevent the escape of the agent. Biological containment includes use of immune personnel and the selection of agents and hosts that will minimise the risk should the agent escape the containment facility. (12 Dec 1998) |
| containment vessel | <radiobiology> Gas-tight shell or other enclosure around a fusion (or fission) reactor, to prevent accidental leakage of radioactive contents. (09 Oct 1997) |
| capital cost | The total investment needed to complete a project and bring it to a commercially operable status. The cost of construction of a new plant. The expenditures for the purchase or acquisition of existing facilities. (05 Dec 1998) |
| cost allocation | The assignment, to each of several particular cost-centres, of an equitable proportion of the costs of activities that serve all of them. Cost-centre usually refers to institutional departments or services. (12 Dec 1998) |
| cost-benefit analysis | A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results. (12 Dec 1998) |
| cost control | The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (12 Dec 1998) |
| cost-effective | A term describing a resource that is available within the time it is needed and is able to meet or reduce electrical power demand at an estimated incremental system cost no greater than that of the least-costly, similarly reliable and available alternative. (05 Dec 1998) |
| cost of illness | The personal cost of acute or chronic disease. The cost to the patient may be an economic, social, or psychological cost or loss to himself, his family, or community. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, quality of life, etc. It differs from health care costs in that this concept is restricted to the cost of providing services related to the delivery of health care rather than an impact on the personal life of the patient. (12 Dec 1998) |
| costs and cost analysis | Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs. (12 Dec 1998) |
| cost savings | Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|